Management of a case of Castleman’s disease coexisting with or occurring after transplanted Hodgkin’s lymphoma

1. Srivastava H, Reddy DS, Shah SN, Shah V. Castleman’s disease. J Oral Maxillofac Pathol. 2020;24:593. DOI: 10.4103/jomfp.JOMFP_283_20808344633967527 Ouvrir le DOISearch in Google Scholar

2. Castleman B, Towne VW. Case records of the Massachusetts General Hospital. Vol. 250. p. 1001-5. DOI: 10.1056/NEJM19540610250230813165944 Ouvrir le DOISearch in Google Scholar

3. Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematology/Oncology Clinics. 2018;32:37-52. DOI: 10.1016/j.hoc.2017.09.00429157618 Ouvrir le DOISearch in Google Scholar

4. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3-17. DOI: 10.1111/j.1365-2141.2004.05311.x15801951 Ouvrir le DOISearch in Google Scholar

5. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-83. DOI: 10.1002/1097-0142(197203)29:3%3C670::AIDCNCR2820290321%3E3.0.CO;2-%23 Ouvrir le DOISearch in Google Scholar

6. Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, et al. The full spectrum of Castleman disease: 273 patients studied over 20 years. British Journal of Haematology. 2018;180:206-16. DOI: 10.1111/bjh.15019 Ouvrir le DOISearch in Google Scholar

7. Beckham TH, Yang JC, Chau KW, Noy A, Yahalom J. Excellent outcomes with surgery or radiotherapy in the management of Castleman disease including a case of oligocentric disease. Clinical Lymphoma Myeloma and Leukemia. 2020;20:685-9. DOI: 10.1016/j.clml.2020.05.002 Ouvrir le DOISearch in Google Scholar

8. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99:2331-6. DOI: 10.1182/blood.V99.7.2331 Ouvrir le DOISearch in Google Scholar

9. Glazer M, Rao VM, Reiter D, McCue P. Isolated Castleman disease of the neck: MR findings. AJNR Am J Neuroradiol. 1995;16:669-71. Search in Google Scholar

10. Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, et al. Diagnosis of Castleman’s disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol. 1996;105:268-76. DOI: 10.1093/ajcp/105.3.268 Ouvrir le DOISearch in Google Scholar

11. Wojtyś M, Piekarska A, Kunc M, Ptaszyński K, Biernat W, Zaucha JM, et al. Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review. J Thorac Dis. 2019;11:4859-74. DOI: 10.21037/jtd.2019.10.73 Ouvrir le DOISearch in Google Scholar

12. Falchi L, Capello D, Palumbo B, Rauco A, Emili R, Cianciulli M, et al. A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy. Eur J Haematol. 2007;79:455-61. DOI: 10.1111/j.1600-0609.2007.00952.x212112517908180 Ouvrir le DOISearch in Google Scholar

13. El-Osta HE, Kurzrock R. Castleman’s disease: from basic mechanisms to molecular therapeutics. The Oncologist. 2011;16:497-511. DOI: 10.1634/theoncologist.2010-0212322812221441298 Ouvrir le DOISearch in Google Scholar

14. Nishi J, Arimura K, Utsunomiya A, Yonezawa S, Kawakami K, Maeno N, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman’s disease. Br J Haematol. 1999;104:482-5. DOI: 10.1046/j.1365-2141.1999.01208.x10086783 Ouvrir le DOISearch in Google Scholar

15. Mohtaram A, Afif M, Sghiri T, Rami A, Latib R, Kettani F, et al. Coexistence of Hodgkin’s Lymphoma and Castleman’s Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy. Case Rep Oncol Med. 2013;2013. DOI: 10.1155/2013/487205387012924381772 Ouvrir le DOISearch in Google Scholar

16. Selvaraj K, Gudipudi D. Recurrent and Hodgkin’s lymphoma-associated multicentric Castleman’s disease in head and neck region. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2020;6:1882. DOI: 10.18203/issn.2454-5929.ijohns20204193 Ouvrir le DOISearch in Google Scholar

17. Maheswaran PR, Ramsay AD, Norton AJ, Roche WR. Hodgkin’s disease presenting with the histological features of Castleman’s disease. Histopathology. 1991;18:249-53. DOI: 10.1111/j.1365-2559.1991.tb00833.x1675190 Ouvrir le DOISearch in Google Scholar

18. Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS. Hodgkin’s disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med. 1994;118:270-4. Search in Google Scholar

19. Gong S, Hijiya N. Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination. Blood, The Journal of the American Society of Hematology. 2017;130:381. DOI: 10.1182/blood-2017-05-78212828729340 Ouvrir le DOISearch in Google Scholar

20. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017;129:1658-68. DOI: 10.1182/blood-2016-11-748855536434328100459 Ouvrir le DOISearch in Google Scholar

• Changes in C-reactive protein, erythrocyte sedimentation rate, human leukocyte antigen-B27, and immunoglobulins A, G, M in patients with ankylosing spondylitis
• Vancomycin-resistant enterococci isolated in tertiary care in Southern Thailand: Prevalence and characterization of biofilm formation
• Change of routine coagulation parameters in plasma samples with different hematocrit values
• Decision tree analysis as predictor tool for in-hospital mortality in critical SARS-CoV-2 infected patients
• Evaluation of muscle elasticity in patients with end-stage renal disease complicated with sarcopenia by real-time shear wave elastography multipoint measurement
• Diagnostic values of glial fibrillary acidic protein, neuron-specific enolase and protein S100β for sepsis-associated encephalopathy
• Association between adiponectin and ADIPOQ (rs 1501299) gene polymorphism in gestational diabetes mellitus patients
• Understanding the key differences between ISO 15189:2022 and ISO 15189:2012 for an improved medical laboratory quality of service